Introduction

Antimicrobial Resistance (AMR) remains one of the most pressing global public health challenges of the twenty-first century. It threatens the effective prevention and treatment of infectious diseases and undermines decades of medical progress. The World Health Organisation (WHO) has described AMR as a silent pandemic with the potential to claim millions of lives annually, if unaddressed. The crisis is not limited to high-income countries as low- and middle-income countries such as Nigeria are disproportionately affected due to weak healthcare systems, unregulated Antimicrobial use, and limited diagnostic capacity. In recent years, researchers have examined AMR through multidisciplinary lenses (biological, social, environmental and policy-oriented) to understand its contemporary dimensions and chart actionable solutions (1,2,3,4,5,6,7)

This article explores emerging themes including biological mechanisms, drivers, surveillance systems, public education, the One Health approach, and the policy and economic dimensions shaping the AMR crisis both globally and within Nigeria.

Biological Basis and Mechanisms of Antimicrobial Resistance

At its core, AMR is a natural evolutionary process in which microorganisms, such as bacteria, fungi, viruses, and parasites, develop mechanisms to withstand antimicrobial agents. However, anthropogenic factors have drastically accelerated this evolution. Recent reviews show that resistance arises through genetic mutations, horizontal gene transfer, efflux pumps, and enzymatic degradation of drugs (8). The spread of mobile genetic elements such as plasmids facilitates the dissemination of resistance genes across species and environments.

The contemporary landscape of AMR also reflects the interplay between old and new resistance mechanisms. While classical forms, such as β-lactamase production, persist newer patterns including carbapenem and colistin resistance, pose critical threats to clinical care. In Nigeria, surveillance data show increasing resistance among Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, particularly to last-resort antibiotics (6). These trends mirror global observations, underscoring the universality of microbial adaptation yet also highlighting the need for local diagnostic and stewardship systems to detect and contain emerging resistance patterns.

Drivers of Antimicrobial Resistance

The drivers of AMR are multifaceted, spanning human, animal, environmental, and economic domains. Misuse and overuse of antibiotics in human health remain major contributors. Empirical antibiotic prescriptions without laboratory confirmation are widespread, especially in developing countries where diagnostic facilities are limited. A 2022 review identified irrational prescription practices, self-medication, and non-prescription sales as persistent drivers (1).

The agricultural sector further compounds the crisis through extensive use of antibiotics for growth promotion and disease prevention in livestock and aquaculture. Runoff from farms contaminates water sources, creating reservoirs for resistant pathogens. Environmental pollution from pharmaceutical waste also sustains selective pressure in microbial ecosystems.

In the Nigerian context, socioeconomic factors significantly exacerbate these issues. Rising drug costs and inequitable access to healthcare encourage patients to seek cheaper, unregulated alternatives, often from informal drug vendors. A 2025 analysis showed that increasing antibiotic prices in Nigeria have indirectly fueled the use of substandard or incomplete antibiotic regimens, thereby accelerating resistance (7). Thus, AMR cannot be viewed solely as a biomedical problem; it is also a socioeconomic and governance issue demanding systemic reform.

Surveillance and Global Monitoring Systems

Effective surveillance is the backbone of AMR control. Surveillance systems allow for data-driven interventions, early detection of resistant strains, and monitoring of Antimicrobial consumption. A 2023 scoping review on global AMR surveillance revealed significant progress in data collection and reporting but also identified key gaps, especially in low-resource settings (2). Many countries, including Nigeria, still rely on fragmented and laboratory-based surveillance with limited national coordination.

The WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) has improved international reporting, but sustainability depends on national investment in laboratory infrastructure and workforce training. Nigeria has made commendable strides with the Nigeria Centre for Disease Control (NCDC) coordinating AMR surveillance through its National Action Plan. However, data from secondary and tertiary healthcare facilities remain inconsistent, and community-level resistance patterns are poorly characterised (6). Strengthening integrated surveillance which includes linking human, animal and environmental sectors, is essential to build a resistant AMR monitoring framework.

Awareness, Behavioural Change and Public Education

Public awareness is a cornerstone of AMR mitigation. Behavioural Change interventions aimed at improving antibiotic use have gained momentum globally. A 2024 systematic review assessing global AMR awareness campaigms showed that most interventions focus on mass media education and professional training, with mixed outcomes (3). While campaigns have improved knowledge, translating awareness into sustained behavioural change remains challenging.

In Nigeria, awareness of AMR among healthcare professionals is relatively high, but the same cannot be said for the general public. Misconceptions about antibiotics as “cure-all” drugs persist. To bridge this gap, culturally tailored and linguistically accessible campaigns are needed. Integrating AMR education into school curricul and community health programs can foster responsible attitudes toward antibiotic use. Moreover, digital advocacy through social media and influencer-led campaigns, offers a new frontier for engaging younger populations.

Healthcare students, as future prescribers and educators, also play a vital role. Embedding AMR-focused courses and stewardship principles into their training can produce a generation of professionals equipped to advocate for rational antimicrobial use.

The One Health Perspective in the Post-COVID-19 Era

The COVID-19 pandemic brought renewed attention to the interconnection between human, animal, and environmental health, which is known as the core of the One Health concept. A 2022 review highlighted that post-pandemic AMR strategies must embrace interdisciplinary learning among health students and professionals to strengthen collective response capacity (4).

During the pandemic, increased empirical antibiotic use to manage viral infections inadvertently fueled resistance trends. This highlights the need to embed One Health frameworks in AMR strategies. In Nigeria, limited coordination between ministries overseeing health, agriculture, and environmental sectors with human health surveillance is imperative.

Globally, the One Health approach is driving innovations such as cross-sectoral data sharing, joint outbreak investigations, and environmentally conscious antibiotic disposal. Nigeria can draw lessons from such international collaborations to strengthen its own multisectoral response.

AMR Policy, Economics and National Action Plans

Policy frameworks are critical i shaping sustainable AMR control efforts. A 2022 comparative review of National Action Plans (NAPs) revealed that while many countries have developed AMR strategies, implementation is hindered by insufficient funding and weak intersectoral coordination (5). Nigeria’s own NAP (2017-2022) outlines five strategic objectives: awareness, surveillance, infection prevention, rational antimicrobial use, and research. However, gaps remain in enforcement, particularly regarding over-the-counter antibiotic sales and quality assurance.

Economic factors further complicate the AMR landscape. As highlighted by the 2025 study on antibiotic costs (7), inflation and reduced purchasing power have made quality antibiotics less affordable for average Nigerians. This situation encourages reliance on informal markets and incomplete treatments, perpetuating resistance cycles. Policymakers must therefore integrate AMR strategies with broader socioeconomic reforms such as ensuring equitable access to affordable, quality-assured antibiotics.

Moreover, global funding initiatives like the Fleming Fund and the Global AMR Innovation Fund can be leveraged to build capacity in diagnostic stewardship, local drug manufacturing, and research. Strengthening research funding in Nigerian universities and teaching hospitals will foster context-specific innovations in antimicrobial discovery and stewardship.

Conclusion

Antimicrobial Resistance stands as a defining health challenge of our time. It is an issue that transcends biology and medicine, touching economics, education and environmental management. The current global discourse underscores that AMR is not a future threat; it is a present reality demanding urgent and coordinated action.

From the molecular intricacies of resistance mechanisms to the societal complexities of drug access and public awareness, contemporary research emphasizes the interconnectedness of factors fueling AMR. For Nigeria, the path forward lies in implementing integrated surveillance systems, enforcing antibiotic regulation, investing in health education, and embedding One Health principles in national policy frameworks.

Ultimately, combating AMR requires a shared sense of responsibility among all stakeholders including governments, healthcare professionals, industry players and the public. Only through collective, evidence-based, and locally informed strategies can we hope to preserve the efficacy of existing antimicrobials and safeguard the future of global health.

Author: Rashidat Yusuf Oyinoyi, 500L student of Pharm D., University of Ilorin, Ilorin, Nigeria.

References

1. Irfan M, Almotiri A, AlZeyadi ZA. Antimicrobial Resistance and Its Drivers-A Review. Antibiotics (Basel). 2022;11(10):1362. Published 2022 Oct 5. doi:10.3390/antibiotics11101362
2. Do PC, Assefa YA, Batikawai SM, Reid SA. Strengthening antimicrobial resistance surveillance systems: a scoping review. BMC Infect Dis. 2023;23(1):593. Published 2023 Sep 11. doi:10.1186/s12879-023-08585-2
3. Gilham EL, Pearce-Smith N, Carter V, Ashiru-Oredope D. Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review. BMC Public Health. 2024;24(1):396. Published 2024 Feb 6. doi:10.1186/s12889-024-17766-w
4. Elmahi OKO, Uakkas S, Olalekan BY, et al. Antimicrobial resistance and one health in the post COVID-19 era: What should health students learn?. Antimicrob Resist Infect Control. 2022;11(1):58. Published 2022 Apr 11. doi:10.1186/s13756-022-01099-7
5. Pallett SJ, Charani E, Hawkins L, et al. National action plans for antimicrobial resistance and variations in surveillance data platforms. Bull World Health Organ. 2023;101(8):501-512F. doi:10.2471/BLT.22.289403
6. Alabi ED, Rabiu AG, Adesoji AT. A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach. One Health. 2025;20:101053. Published 2025 Apr 27. doi:10.1016/j.onehlt.2025.101053
7. Gulumbe BH, Abdulrahim A, Ibrahim MN. Rising antibiotic costs as a potential driver of antimicrobial resistance in Nigeria. Discover Public Health. 2025;22(8). doi:10.1186/s12982-025-00398-9
8. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482-501. Published 2018 Jun 26. doi:10.3934/microbiol.2018.3.482